Glenmark Life Sciences slipped 9.76% to Rs 938 after the company’s standalone net profit declined 19.72% to Rs 95.32 core on 14.86% slide in revenue from operatios to Rs 506.88 crore in Q2 FY25 over Q2 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
